mRNA COVID-19 vaccine - BioNet Asia
Latest Information Update: 25 Apr 2023
At a glance
- Originator BioNet-Asia
- Class COVID-19 vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown COVID 2019 infections
Most Recent Events
- 25 Apr 2023 Clinical trials in COVID-2019 infections (Prevention) in Thailand (Parenteral), prior to April 2023 (BioNet-Asia pipeline, April 2023)